Denne side blev automatisk oversat, og nøjagtigheden af ​​oversættelsen er ikke garanteret. Der henvises til engelsk version for en kildetekst.

Final Examination Stress and Bowel Symptoms

17. september 2026 opdateret af: Demet Öztürk, Lokman Hekim University

The Effect of Final Examination Stress on Bowel Symptoms in University Students

This prospective observational study aims to investigate the association between final examination stress and bowel symptoms in university students. Participants will be evaluated during the final examination period, which represents a naturally occurring period of increased academic stress. Bowel-related symptoms, including constipation-related complaints, defecation-related pain, stool characteristics, and urgency, will be assessed. Participants will also complete a 7-day diary to record bowel characteristics and selected lifestyle factors, including sleep duration, daily step count, and fluid intake. These factors will be examined as potential variables associated with bowel symptoms during the examination period.

Studieoversigt

Detaljeret beskrivelse

University students may experience increased psychological stress during final examination periods due to academic workload, performance expectations, and time pressure. Stress may influence gastrointestinal function through alterations in the brain-gut axis, autonomic nervous system activity, gastrointestinal motility, and visceral sensitivity. Examination periods may also be accompanied by changes in daily lifestyle behaviors, such as sleep duration, physical activity, and fluid intake, which may further influence bowel function.

This prospective, observational, analytical study is designed to evaluate bowel symptoms among university students during the final examination period. Participants will complete a sociodemographic and clinical information form and will be assessed for constipation-related symptoms using Rome IV-based questions. Additional bowel-related characteristics, including pain during defecation, pain intensity and location, urgency to defecate, and stool type, will be recorded.

Participants will also complete a 7-day follow-up diary during the final examination period. The diary will include daily records of defecation-related symptoms and stool characteristics as well as daily fluid intake, step count, and sleep duration. Daily step count and sleep duration will be considered potential lifestyle-related factors associated with bowel symptoms rather than primary outcomes.

The primary objective of the study is to investigate bowel symptoms during a period of final examination stress in university students. Secondary objectives are to examine the relationships between bowel symptoms and selected lifestyle-related factors, particularly sleep duration, physical activity, and fluid intake. No therapeutic, pharmacological, exercise-based, or invasive intervention will be administered as part of the study.

Undersøgelsestype

Observationel

Tilmelding (Anslået)

100

Deltagelseskriterier

Forskere leder efter personer, der passer til en bestemt beskrivelse, kaldet berettigelseskriterier. Nogle eksempler på disse kriterier er en persons generelle helbredstilstand eller tidligere behandlinger.

Berettigelseskriterier

Aldre berettiget til at studere

18 år og ældre (Voksen, Ældre voksen)

Tager imod sunde frivillige

Ja

Køn, der er berettiget til at studere

Alle

Prøveudtagningsmetode

Ikke-sandsynlighedsprøve

Studiebefolkning

The study population will consist of undergraduate university students aged 18 years or older who are enrolled in courses with final examinations during the study period. Eligible students who meet the predefined inclusion and exclusion criteria and voluntarily agree to participate will be included in the study.

Participants will be evaluated during the final examination period, which represents a naturally occurring period of academic stress. During this period, bowel-related symptoms and selected lifestyle factors, including sleep duration, daily step count, and water intake, will be assessed. Participants will also complete a 7-day follow-up diary to record daily bowel characteristics and related symptoms.

Beskrivelse

Inclusion Criteria:

  • Being 18 years of age or older
  • Being an undergraduate university student
  • Being enrolled in courses with final examinations during the study period
  • Being able to complete the study assessments and the 7-day follow-up diary during the final examination period
  • Being able to read and understand Turkish
  • Voluntarily agreeing to participate in the study and providing informed consent

Exclusion Criteria:

  • Having a diagnosed organic gastrointestinal disease that may substantially affect bowel function, such as inflammatory bowel disease, celiac disease, or gastrointestinal malignancy
  • Having a history of major gastrointestinal or pelvic surgery that may affect bowel function
  • Regular use of medications that directly affect bowel motility, such as laxatives or antidiarrheal medications
  • Having an acute gastrointestinal infection, including acute diarrhea or vomiting, during the assessment period
  • Failing to adequately complete the study assessments or the 7-day follow-up diary

Studieplan

Dette afsnit indeholder detaljer om studieplanen, herunder hvordan undersøgelsen er designet, og hvad undersøgelsen måler.

Hvordan er undersøgelsen tilrettelagt?

Design detaljer

  • Observationsmodeller: OTHER
  • Tidsperspektiver: PROSPECTIVE

Kohorter og interventioner

Gruppe / kohorte
Intervention / Behandling
University Students During the Final Examination Period

University students who meet the eligibility criteria and participate in the study during the final examination period will constitute a single observational cohort. Participants will undergo assessment of bowel symptoms and related lifestyle factors during the study period. No allocation or randomization will be performed.

Participants will complete assessments of bowel symptoms and a 7-day diary during the final examination period. The diary will include daily records of bowel-related symptoms, stool characteristics, fluid intake, step count, and sleep duration. No treatment, medication, exercise program, or other therapeutic intervention will be administered.

Hvad måler undersøgelsen?

Primære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Constipation-Related Bowel Symptoms
Tidsramme: Baseline

Constipation-related bowel symptoms will be assessed using Rome IV-based questions. The assessment (Rome IV criterias) will include defecation frequency, painful or difficult defecation, large-diameter stools, stool withholding behaviors, sensation of a large fecal mass in the rectum, fecal incontinence, and duration of symptoms.

Baseline

Sekundære resultatmål

Resultatmål
Foranstaltningsbeskrivelse
Tidsramme
Defecation-Related Pain
Tidsramme: Daily for 7 consecutive days during the final examination period

Participants will record the presence or absence of pain during defecation each day. When pain is present, its location (abdominal or anal region) and intensity will also be recorded. Pain intensity will be rated on a numerical scale ranging from 0 to 10, with higher scores indicating greater pain intensity.

Daily for 7 consecutive days during the final examination period
Defecation Urgency
Tidsramme: Daily for 7 consecutive days during the final examination period

Participants will record the severity of urgency to defecate each day as mild, moderate, or severe.

Daily for 7 consecutive days during the final examination period
Stool Type
Tidsramme: Daily for 7 consecutive days during the final examination period

Participants will record their daily stool type according to the stool form chart provided in the study diary.

Daily for 7 consecutive days during the final examination period
Daily Step Count
Tidsramme: Daily for 7 consecutive days during the final examination period

Daily step count will be recorded using data obtained from participants' personal smartphones, smartwatches, or other step-counting devices. The mean daily step count across the 7-day monitoring period will also be calculated and evaluated as a lifestyle-related factor potentially associated with bowel symptoms.

Daily for 7 consecutive days during the final examination period
Sleep Duration
Tidsramme: Daily for 7 consecutive days during the final examination period

Participants will record the total duration of sleep for each day in hours. The mean daily sleep duration across the 7-day monitoring period will be calculated and evaluated as a potential factor associated with bowel symptoms.

Daily for 7 consecutive days during the final examination period
Daily Water Intake
Tidsramme: Daily for 7 consecutive days during the final examination period

Participants will record their total daily water intake in milliliters. The mean daily water intake across the 7-day monitoring period will be calculated and examined in relation to bowel symptoms.

Daily for 7 consecutive days during the final examination period

Samarbejdspartnere og efterforskere

Det er her, du vil finde personer og organisationer, der er involveret i denne undersøgelse.

Datoer for undersøgelser

Disse datoer sporer fremskridtene for indsendelser af undersøgelsesrekord og resumeresultater til ClinicalTrials.gov. Studieregistreringer og rapporterede resultater gennemgås af National Library of Medicine (NLM) for at sikre, at de opfylder specifikke kvalitetskontrolstandarder, før de offentliggøres på den offentlige hjemmeside.

Studer store datoer

Studiestart (Anslået)

1. november 2026

Primær færdiggørelse (Anslået)

1. december 2026

Studieafslutning (Anslået)

30. december 2026

Datoer for studieregistrering

Først indsendt

17. september 2026

Først indsendt, der opfyldte QC-kriterier

17. september 2026

Først opslået (Faktiske)

24. september 2026

Opdateringer af undersøgelsesjournaler

Sidste opdatering sendt (Faktiske)

24. september 2026

Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier

17. september 2026

Sidst verificeret

1. september 2026

Mere information

Begreber relateret til denne undersøgelse

Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter

Studerer et amerikansk FDA-reguleret lægemiddelprodukt

Ingen

Studerer et amerikansk FDA-reguleret enhedsprodukt

Ingen

Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .

Abonner